Physician profile
Juan He
NPI 1255655403
$1,209.14
in general payments reported to CMS, 2019-2025
17 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $391 · 2022: $319 · 2023: $171 · 2024: $145 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $345.83 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $164.75 | 2021-2024 | Xtampza |
| Grt US Holding, INC. | $124.80 | 2022 | |
| Abbott Laboratories | $122.42 | 2021-2022 | |
| Relievant Medsystems, INC. | $120.73 | 2021-2022 | |
| Biotronik Nro, INC. | $109.76 | 2024-2025 | Prospera |
| Trevena, INC. | $42.82 | 2022-2023 | Olinvyk |
| Boston Scientific Corporation | $29.58 | 2025 | General - Pain Management |
| Averitas Pharma INC. | $19.99 | 2023 | Qutenza |
| Tersera Therapeutics LLC | $18.07 | 2023 | Prialt |
| Scilex Pharmaceuticals INC. | $17.14 | 2021 | |
| Valinor Pharma, LLC | $17.06 | 2025 | Movantik |
| Saluda Medical Americas, INC. | $16.79 | 2024 | Evoke |
| Redhill Biopharma INC. | $16.50 | 2021 | |
| Almatica Pharma LLC | $15.69 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.77 | 2021 | |
| Forte Bio-Pharma LLC | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.